Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
59.40
+3.29 (5.86%)
At close: Dec 20, 2024, 4:00 PM
59.50
+0.10 (0.17%)
After-hours: Dec 20, 2024, 5:25 PM EST
Exact Sciences Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Exact Sciences stock have an average target of 72.8, with a low estimate of 60 and a high estimate of 90. The average target predicts an increase of 22.56% from the current stock price of 59.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 10 | 10 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 1 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 14 | 14 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $75 → $72 | Strong Buy | Maintains | $75 → $72 | +21.21% | Dec 13, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $82 → $86 | Strong Buy | Maintains | $82 → $86 | +44.78% | Nov 26, 2024 |
| BTIG | BTIG | Strong Buy Maintains $65 → $75 | Strong Buy | Maintains | $65 → $75 | +26.26% | Nov 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $85 → $75 | Buy | Maintains | $85 → $75 | +26.26% | Nov 11, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $80 → $75 | Strong Buy | Maintains | $80 → $75 | +26.26% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
2.80B
from 2.50B
Increased by 11.81%
Revenue Next Year
3.11B
from 2.80B
Increased by 11.41%
EPS This Year
-1.23
from -1.13
EPS Next Year
-0.44
from -1.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.9B | 3.3B | 3.7B | |||
| Avg | 2.8B | 3.1B | 3.5B | |||
| Low | 2.7B | 2.9B | 3.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 15.3% | 17.7% | 19.7% | |||
| Avg | 11.8% | 11.4% | 11.1% | |||
| Low | 7.1% | 3.0% | -2.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.12 | -0.14 | 0.85 | |||
| Avg | -1.23 | -0.44 | 0.24 | |||
| Low | -1.36 | -1.17 | -1.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.